Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|April 12, 2014
Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acidMartina Ulrich, Giovanni Pellacani, Carlos Ferrandiz, et al.
Journal of Cutaneous Pathology|September 21, 2007
Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samplesJose-Manuel Carrascosa, Gustavo Tapia, Isabel Bielsa, et al.
European Journal of Dermatology : EJD|October 29, 2008
Development of a treatment algorithm for actinic keratoses: a European ConsensusEggert Stockfleth, Carlos Ferrandiz, Jean Jacques Grob, et al.
Dermatology (Basel, Switzerland)|January 25, 2008
What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian regionAmaro García-Diez, Carlos Ferrandiz Foraster, Francisco Vanaclocha Sebastián, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 6, 2004
Specialty clinics for the dermatologic care of solid-organ transplant recipientsLeslie J Christenson, Alexandra Geusau, Carlos Ferrandiz, et al.
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
The Journal of Dermatological Treatment|September 15, 2015
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohortIgnacio García-Doval, Beatriz Pérez-Zafrilla, Carlos Ferrandiz, et al.
Archives of Dermatology|April 18, 2012
Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trialsIgnacio Garcia-Doval, Gregorio Carretero, Francisco Vanaclocha, et al.
The Journal of Investigative Dermatology|September 29, 2016
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM RegistryPaula Dávila-Seijo, Esteban Dauden, M A Descalzo, et al.
Pageof 1